Viewing Study NCT03346369

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-05-09 @ 12:14 PM
Study NCT ID: NCT03346369
Status: UNKNOWN
Last Update Posted: 2021-01-08
First Post: 2017-03-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
Sponsor: Universitair Ziekenhuis Brussel
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Secondary Hyperoxaluria View
None Nephrolithiasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nephrolithiasis View
None Urolithiasis View
None Secondary Hyperoxaluria View
None Hyperoxaluria View
None Lanthanum Carbonate View
None Phosphate Binder View